The household economic burden of non-communicable diseases in 18 countries
- PMID: 32133191
- PMCID: PMC7042605
- DOI: 10.1136/bmjgh-2019-002040
The household economic burden of non-communicable diseases in 18 countries
Abstract
Background: Non-communicable diseases (NCDs) are the leading cause of death globally. In 2014, the United Nations committed to reducing premature mortality from NCDs, including by reducing the burden of healthcare costs. Since 2014, the Prospective Urban and Rural Epidemiology (PURE) Study has been collecting health expenditure data from households with NCDs in 18 countries.
Methods: Using data from the PURE Study, we estimated risk of catastrophic health spending and impoverishment among households with at least one person with NCDs (cardiovascular disease, diabetes, kidney disease, cancer and respiratory diseases; n=17 435), with hypertension only (a leading risk factor for NCDs; n=11 831) or with neither (n=22 654) by country income group: high-income countries (Canada and Sweden), upper middle income countries (UMICs: Brazil, Chile, Malaysia, Poland, South Africa and Turkey), lower middle income countries (LMICs: the Philippines, Colombia, India, Iran and the Occupied Palestinian Territory) and low-income countries (LICs: Bangladesh, Pakistan, Zimbabwe and Tanzania) and China.
Results: The prevalence of catastrophic spending and impoverishment is highest among households with NCDs in LMICs and China. After adjusting for covariates that might drive health expenditure, the absolute risk of catastrophic spending is higher in households with NCDs compared with no NCDs in LMICs (risk difference=1.71%; 95% CI 0.75 to 2.67), UMICs (0.82%; 95% CI 0.37 to 1.27) and China (7.52%; 95% CI 5.88 to 9.16). A similar pattern is observed in UMICs and China for impoverishment. A high proportion of those with NCDs in LICs, especially women (38.7% compared with 12.6% in men), reported not taking medication due to costs.
Conclusions: Our findings show that financial protection from healthcare costs for people with NCDs is inadequate, particularly in LMICs and China. While the burden of NCD care may appear greatest in LMICs and China, the burden in LICs may be masked by care foregone due to costs. The high proportion of women reporting foregone care due to cost may in part explain gender inequality in treatment of NCDs.
Keywords: cardiovascular disease; diabetes; health economics; health insurance; health systems.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures

Similar articles
-
Financial risk protection against noncommunicable diseases: trends and patterns in Bangladesh.BMC Public Health. 2022 Sep 30;22(1):1835. doi: 10.1186/s12889-022-14243-0. BMC Public Health. 2022. PMID: 36175951 Free PMC article.
-
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.Lancet. 2016 Jan 2;387(10013):61-9. doi: 10.1016/S0140-6736(15)00469-9. Epub 2015 Oct 20. Lancet. 2016. PMID: 26498706
-
Consumption displacement in households with noncommunicable diseases in Bangladesh.PLoS One. 2018 Dec 13;13(12):e0208504. doi: 10.1371/journal.pone.0208504. eCollection 2018. PLoS One. 2018. PMID: 30543648 Free PMC article.
-
Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries.In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 6. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 6. PMID: 30212160 Free Books & Documents. Review.
-
The financial burden from non-communicable diseases in low- and middle-income countries: a literature review.Health Res Policy Syst. 2013 Aug 16;11:31. doi: 10.1186/1478-4505-11-31. Health Res Policy Syst. 2013. PMID: 23947294 Free PMC article. Review.
Cited by
-
Health and economic burden of disease of sugar-sweetened beverage consumption in four Latin American and Caribbean countries: a modelling study.BMJ Open. 2023 Feb 7;13(2):e062809. doi: 10.1136/bmjopen-2022-062809. BMJ Open. 2023. PMID: 36750287 Free PMC article.
-
A network analysis of patient referrals in two district health systems in Tanzania.Health Policy Plan. 2021 Mar 26;36(2):162-175. doi: 10.1093/heapol/czaa138. Health Policy Plan. 2021. PMID: 33367559 Free PMC article.
-
To what extent did households in developing countries forgo needed healthcare during the COVID-19 pandemic? Repeated survey estimates from 25 countries in 2020 and 2021.BMJ Public Health. 2024 Dec 22;2(2):e001027. doi: 10.1136/bmjph-2024-001027. eCollection 2024 Dec. BMJ Public Health. 2024. PMID: 40018592 Free PMC article.
-
Elites can take care of themselves - Comment on COVID-19: the rude awakening for the political elite in low-income and middle-income countries.BMJ Glob Health. 2020 Jul;5(7):e003063. doi: 10.1136/bmjgh-2020-003063. BMJ Glob Health. 2020. PMID: 32641286 Free PMC article. No abstract available.
-
Reform of the Health Insurance Funding Model to Improve the Care of Noncommunicable Diseases Patients in Saudi Arabia.Healthcare (Basel). 2022 Nov 16;10(11):2294. doi: 10.3390/healthcare10112294. Healthcare (Basel). 2022. PMID: 36421618 Free PMC article.
References
-
- World Health Organization . Technical note: how who will report in 2017 to the United nations General assembly on the progress achieved in the implementation of commitments included in the 2011 un political Declaration and 2014 un outcome document on NCDS. Geneva: World Health Organization, 2017.
-
- Attaei MW, Khatib R, McKee M, et al. . Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the pure study data. The Lancet Public Health 2017;2:e411–9. 10.1016/S2468-2667(17)30141-X - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources